Publications by Philip Berry - ePrints

Browsing publications by Philip Berry.

Newcastle Authors	Title	Year
Professor Gareth Veal Philip Berry	Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma	2024
Dr Catherine Gowland Philip Berry Julie Errington Professor Gareth Veal	Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study	2021
Mankaran Singh Dr Helen Blair Philip Berry Professor Olaf Heidenreich	Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS	2020
Dr Karen Barker Philip Berry Professor Gareth Veal Dr John Anderson	In vivo Modelling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis	2019
Dr Anastasia Hepburn Laura Wilson Evangelia Kounatidou Amy Barnard Philip Berry et al.	Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)	2019
Dr Rosanna Jackson Philip Berry Julie Errington Professor Julie Irving Professor Gareth Veal et al.	Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia - a report from the UKALL 2011 trial	2019
Professor Gareth Veal Philip Berry	Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste	2019
Dr Lindi Chen Philip Berry Dr Jennifer Bonner Calum Kirk Dr Katrina Wood et al.	Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma	2019
Dr Anastasia Hepburn Laura Wilson Evangelia Kounatidou Amy Barnard Philip Berry et al.	The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance	2019
Philip Berry	Cancer-related health behaviours of young people not in education, employment or training ('NEET'): a cross-sectional study	2018
Monique Zangarini Philip Berry Professor Gareth Veal	Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts	2018
Dr Lynsey McKenzie Hasan Issa Sandeep Potluri Dr Helen Blair Asmida Isa et al.	The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation	2018
Dr Sally Coulthard Sarah McGarrity Dr Kiran Sahota Philip Berry Dr Chris Redfern et al.	Three Faces of Mercaptopurine Cytotoxicity in vitro: Methylation, Nucleotide Homeostasis and Deoxythioguanosine in DNA	2018
Dr Sally Coulthard Philip Berry Sarah McGarrity Dr Chris Redfern	Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone	2017
Monique Zangarini Philip Berry Julieann Sludden Professor Gareth Veal	Development and validation of a LC-MS/MS method for the quantification of the checkpoint kinase 1 inhibitor SRA737 in human plasma	2017
Monique Zangarini Professor Neil Rajan Dr Marina Danilenko Philip Berry Professor Gareth Veal et al.	Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors	2017
Dr Lindi Chen Philip Berry Dr Jennifer Bonner Dr Katrina Wood Professor Gareth Veal et al.	In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in TP53 wild-type orthotopic models of neuroblastoma	2017
Professor Gareth Veal Carine Boue Charlotte Lecour Annette Otto Maryam Rastegari et al.	Investigating the roles and training of paediatric research nurses working across Europe: a questionnaire-based survey	2017
Dr Sally Coulthard Philip Berry Sarah McGarrity Dr Chris Redfern	A Novel Assay for The Direct Detection of Deoxythioguanosine (DTG) in DNA from Patients On Azathioprine Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)	2016
Philip Berry Dr Anthony Oxley Professor Georg Lietz	A Retinol Isotope Dilution Equation Predicts Both Group and Individual Total Body Vitamin A Stores in Adults Based on Data from an Early Postdosing Blood Sample	2016
Dr Sally Coulthard Philip Berry Sarah McGarrity Abdul-Haq Ansari Dr Chris Redfern et al.	Deoxythioguanosine (DTG) in DNA as a Pharmacological Endpoint of Thiopurine Treatment in Inflammatory Bowel Disease Patients	2016
Dr Sally Coulthard Philip Berry Sarah McGarrity Dr Chris Redfern	Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients	2016
Dr Sally Coulthard Philip Berry Sarah McGarrity Dr Chris Redfern	Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients	2016
Dr Anthony Oxley Philip Berry Professor Georg Lietz	Plasma Retinol Kinetics and β-Carotene Bioefficacy Are Quantified by Model-Based Compartmental Analysis in Healthy Young Adults with Low Vitamin A Stores	2016
Professor Georg Lietz Dr Anthony Oxley Philip Berry Professor John Hesketh Dr Franck Tourniaire et al.	β-carotene (BC) bioconversion is similar in men and women	2015
Dr Anthony Oxley Philip Berry Gordon Taylor Dr Joe Cowell Dr Michael Hall et al.	An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion and vitamin A status in humans	2014
Dr Sally Coulthard Philip Berry Sarah McGarrity Dr Chris Redfern	Direct Detection of Thiopurine Metabolites in Erythrocytes and Leukocytes Using a Novel LCMS/MS Method to Interrogate Drug Response and in vivo Metabolism	2014
Emily Mould Philip Berry Dr David Jamieson Dr Chris Hill Dr Celine Cano et al.	Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity	2014
Dr Hyun Jin Park Professor Georg Lietz Dr Anthony Oxley Professor Alan Boddy Philip Berry et al.	Simplified approaches for estimating vitamin A stores and β-carotene bioconversion in humans	2014
Dr Lindi Chen Dr Yan Zhao Dr Gail Halliday Philip Berry Professor Herbie Newell et al.	Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma	2014
Emily Mould Stephanie Burnell Philip Berry Professor Herbie Newell Dr Elaine Willmore et al.	The novel and contrasting roles of ATM and DNA-PK in the response of cells to microtubule-targeting anticancer agents	2014
James Murray Huw Thomas Philip Berry Suzanne Kyle Dr Miranda Patterson et al.	Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules	2014
Dr Anthony Oxley Philip Berry Professor John Hesketh Professor Alan Boddy Professor Georg Lietz et al.	Gender differences in retinol metabolism are independent of β-carotene bioconversion	2013
Emily Mould Philip Berry Dr David Jamieson Dr Chris Hill Niu Tan et al.	The DNA-PK inhibitor, NU7441, sensitises cancer cells to microtubule-targeting agents and modulates vincristine efflux in multidrug resistant cells	2013
Professor Colin Ingram Philip Berry Dr John Ingram	Differential expression of GABA-A receptor sub-unit and glutamic acid decarboxylase (GAD) mRNAs in the forebrain of Fischer and Lewis rats	2005